Answers are grounded in this paper and cite their sources.
Metabolic disorders from a high-fat diet impair salivary gland integrity, and the effect of tirzepatide on these glands is unknown. We investigated tirzepatide’s effects on high-fat diet (HFD)-induced salivary gland injury in rats. Forty adult male rats were randomly assigned to four groups: control (G1), HFD-fed (G2), HFD + saline (G3), and HFD + tirzepatide (G4). We assessed metabolic parameters, oxidative stress markers, inflammatory cytokines (TNF-α, IL-1β), caspase-3 concentration, stimulated salivary flow rate (SSFR), histopathology, and mast cell morphometry. HFD feeding caused insulin resistance and dyslipidemia, increased oxidative stress, TNF-α, IL-1β, and caspase-3 in salivary gland homogenate, histological damage to salivary gland tissue, increased mast cell indices, and collagen deposition. Tirzepatide significantly improved metabolic abnormalities and attenuated oxidative stress and inflammation, reduced caspase-3, mast cell, and fibrotic changes, and preserved salivary gland structure. SSFR showed no significant differences in pairwise comparisons. HFD-fed groups (G2 and G3) showed a reduced stimulated salivary rate per 100 g body weight (mL/15 min/100 g BW) compared with the control (G1). The tirzepatide-treated group (G4) had an improved stimulated salivary rate per 100 g BW, with no significant difference from the control (G1). The data suggest that tirzepatide ameliorates HFD-induced salivary gland injury, and this effect was associated with reduced oxidative stress, inflammatory cytokine levels (TNF-α, IL-1β), and caspase-3. The preservation of absolute SSFR despite marked tissue damage suggests that structural damage may occur without a concomitant reduction in overall stimulated salivary secretion.
No takes yet. Share an insight, caveat, or question.
Morgan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: